Advanced Search >

Risk Minimisation Materials

Physician Information and Management Guidelines for Patients with Multiple Sclerosis receiving TYSABRI Therapy

This guidance document has been developed for those physicians initiating and supervising TYSABRI in accordance with the conditions of the Marketing Authorisation of the drug.

For Healthcare Professionals

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue